Supriya Life Sciences Q2 Results
- BSE: 543434
- NSE: SUPRIYA
- ISIN: INE07RO01027
- Sector: Biotechnology & Drugs
BSE
792.4
-9.40 (-1.17%)
-9.40 (-1.17%)Volume55.59 K
Updated: Mon 25 Nov, 2024 | 15:41:42
NSE
793.2-13.65 (-1.69%)
-13.65 (-1.69%)Volume1.86 M
Updated: Mon 25 Nov, 2024 | 15:42:04
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹166.10 Cr.(3.41%)
- Operating Profit₹59.97 Cr.(3.61%)
- Profit After Tax₹46.15 Cr.(3.37%)
- Operating Margin36.11%(82.14%)
Note: Comparison is on YoY basis
Quarterly - Supriya Life Sciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 166.10 | 132.02 | -% | 140.09 | -% |
| Selling/ General/ Admin Expenses Total | 19.68 | 15.43 | -% | 17.50 | -% |
| Depreciation/ Amortization | 4.74 | 3.95 | -% | 3.98 | -% |
| Other Operating Expenses Total | 35.73 | 24.88 | -% | 29.20 | -% |
| Total Operating Expense | 106.13 | 91.49 | -% | 112.32 | -% |
| Operating Income | 59.97 | 40.54 | -% | 27.77 | -% |
| Net Income Before Taxes | 62.06 | 42.64 | -% | 29.78 | -% |
| Net Income | 46.15 | 28.51 | -% | 23.88 | -% |
| Diluted Normalized EPS | 5.71 | 3.54 | -% | 2.97 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST